Compounds > 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide
Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and thromboxane b2

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)		Trials
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)		Recent Studies (post-2010)
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)		Studies
(thromboxane b2)		Trials
(thromboxane b2)		Recent Studies (post-2010) (thromboxane b2)
73087,483715485

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lefferts, PL; Lu, W; Snapper, JR; Thabes, JS1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and thromboxane b2

ArticleYear
Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:1

    Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Endothelins; Endotoxemia; Female; Hypertension, Pulmonary; Lymph; Male; Premedication; Pulmonary Wedge Pressure; Sheep; Thromboxane B2

1998